As a skeletal protein, α-SMA is the most extensively used biomarkers of CAFs and is related to transforming growth factor-beta (TGF-β) production and high contractility of cancer cells (Kunz-Schughart & Knuechel, 2002; Yoshida, 2020). This evidence concerns the gene ACTA1 and cancer.